𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Identification of CCDC62-2 as a novel cancer/testis antigen and its immunogenicity

✍ Scribed by Shohei Domae; Yoichi Nakamura; Yurika Nakamura; Akiko Uenaka; Hisashi Wada; Masao Nakata; Mikio Oka; Koji Kishimoto; Goichi Tsukamoto; Yasuto Yoshihama; Junji Matsuoka; Akira Gochi; Shigeru Kohno; Takashi Saika; Akira Sasaki; Eiichi Nakayama; Toshiro Ono

Publisher
John Wiley and Sons
Year
2009
Tongue
French
Weight
293 KB
Volume
124
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Cancer/testis (CT) antigens are expressed in normal germ line tissues and various cancers. They are considered promising target molecules for immunotherapy for patients with various cancers. To identify CT antigens, we performed serological identification of antigens by recombinant expression cloning. The humoral immune response of cancer patients against a newly defined antigen was analyzed. A testicular cDNA library was immunoscreened with serum obtained from a gastric adenocarcinoma patient whose primary cancer had regressed once and most liver metastasies had disappeared transiently. We isolated 55 positive cDNA clones comprising 23 different genes. They included 4 genes with testis‐specific expression profiles in the Unigene database, including coiled‐coil domain containing 62 (CCDC62). RT‐PCR analysis showed that the expression of 2 splice variants of CCDC62 was restricted to the testis in normal adult tissues. In malignant tissues, CCDC62 variant 2 (CCDC62‐2) was aberrantly expressed in a variety of cancers, including stomach cancer. A serological survey of 191 cancer patients with a range of different cancers by ELISA revealed antibodies to CCDC62‐2 in 13 patients, including stomach cancer. None of the 41 healthy donor serum samples were reactive in the same test. The serum reaction against CCDC62‐2 was confirmed by western blot. CCDC62‐2 is a CT antigen that is immunogenic in cancer patients. © 2008 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

A yeast two-hybrid system using Sp17 ide
A yeast two-hybrid system using Sp17 identified Ropporin as a novel cancer–testis antigen in hematologic malignancies
✍ Zhanfei Li; Wei Li; Farouk Meklat; Zhiqing Wang; Jian Zhang; Yana Zhang; Seah H. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 144 KB

## Abstract Since most intracellular proteins are expressed with their ligands, ligands of cancer–testis (CT) antigens may also be CT in their distribution. Applying Sperm protein 17 (Sp17) as the bait in a yeast 2‐hybrid system of a testicular cDNA library, 17 interacting clones were isolated and

Immunoscreening of a cDNA library from a
Immunoscreening of a cDNA library from a lung cancer cell line using autologous patient serum: Identification of XAGE-1b as a dominant antigen and its immunogenicity in lung adenocarcinoma
✍ Ali Mohamed Ali Eldib; Toshiro Ono; Michihide Shimono; Miho Kaneko; Kazuhiko Nak 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 170 KB

## Abstract By serologic identification of antigens by recombinant expression cloning (SEREX) analysis using an autologous lung adenocarcinoma cell line, OU‐LU‐6, as a cDNA library source, we demonstrated that XAGE‐1 was the dominant antigen recognized by serum from a patient. By immunoscreening, w

Detection of melanoma-derived cancer-tes
Detection of melanoma-derived cancer-testis antigen CT16 in patient sera by a novel immunoassay
✍ Pekka Rappu; Camilla Nylund; Noora Ristiniemi; Janne Kulpakko; Pia Vihinen; Mica 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 677 KB

## Abstract Cancer‐testis antigens (CTAs) are expressed mainly in various cancer tissues and in testis or placenta. Because of their restricted expression pattern, the CTAs can be potentially used for vaccine development and diagnostic applications. CTA CT16 has been found to be expressed in lung a

Carcinoembryonic antigen (CEA): Its role
Carcinoembryonic antigen (CEA): Its role as a monitor of radiation therapy for colorectal cancer
✍ Paul H. Sugarbaker; William D. Bloomer; Ellen D. Corbett; John T. Chaffey 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 2 views

Serial CEA radioimmunoassays have been performed on patients receiving radiation therapy preoperatively or as treatment of recurrent or metastatic colorectal cancer. Pretreatment circulating CEA titers which were elevated showed a significant decrease with accumulating doses of irradiation, indicati

HLA-A2-restricted CTL epitopes of a nove
HLA-A2-restricted CTL epitopes of a novel lung cancer-associated cancer testis antigen, cell division cycle associated 1, can induce tumor-reactive CTL
✍ Michiko Harao; Shinya Hirata; Atsushi Irie; Satoru Senju; Tetsuya Nakatsura; Hir 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 695 KB

## Abstract Toward the development of a novel cancer immunotherapy, we have previously identified several tumor‐associated antigens (TAAs) and the epitopes recognized by human histocompatibility leukocyte (HLA)‐A2/A24‐restricted cytotoxic T lymphocyte (CTL). In this study, we tried to identify a TA